Anna Lukyanova, COO of life sciences compliance proivider Arriello, explains why tight project management is essential for success in pharma outsourcing.
Bryan Edwards distribution manager & responsible person at Almac Pharma Services details the financial and custom considerations for bringing an orphan drug to market.
Contract development and manufacturing organisation (CDMO) Cobra Biologics and the Karolinska Institutet (KI) have been awarded €3 million in emergency funding to take a DNA vaccine for Covid-19 through phase I clinical trial testing.
Marie Manley, partner at law firm Sidley Austin, and associates, look at how UK and EU life sciences are responding to the regulatory requirements presented by Covid-19.
Whilst the outbreak of the latest strain of Coronavirus – Covid-19 – is a scare for healthcare systems and citizens worldwide, it presents an opportunity to pharma and government to reassess the way they work together.
Professor Ian Marison (BCC) and Dr Peter Levison (Pall Corporation) speak to EPM about the most pressing challenges facing the biopharma industry and what needs to be done to tackle the growing skills shortage.
Craig Stanford, head of Vendor Managed Services, Rubix, explains how vendor managed services make it easier for pharmaceutical businesses to purchase and restock consumables.
